The Tmp gene, encoding a membrane protein, is a c-Myc target with a tumorigenic activity

Molecular and Cellular Biology

Volumn 19, Issue 5, 1999, Pages 3529-3539

  Ben Porath, Ittai ^a   Yanuka, Ofra ^a   Benvenisty, Nissim ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CARCINOGENESIS; CELL CONTACT; CELL PROLIFERATION; CELL TRANSFORMATION; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE TARGETING; MOUSE; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RAT;

ANIMALIA; MUS MUSCULUS; RODENTIA;

EID: 0032954035     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.19.5.3529     Document Type: Article

References (74)

1. Auvinen, M., A. Laine, A. Paasinen-Sohns, A. Kangas, L. Kangas, O. Saksela, L. C. Andersson, and E. Holtta. 1997. Human ornithine decarboxylase-overproducing NIH3T3 cells induce rapidly growing, highly vascularized tumors in nude mice. Cancer Res. 57:3016-3025.
2. Auvinen, M., A. Paasinen, L. C. Andersson, and E. Hollta. 1992. Ornithine decarboxylase activity is critical for cell transformation. Nature 360:355-358.
3. Ayer, D. E., L. Kretzner, and R. N. Eisenman. 1993. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:211-222.
4. Bello-Fernandez, C., G. Packham, and J. L. Cleveland. 1993. The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad. Sci. USA 90:7804-7808.
5. Ben-Porath, I., and N. Benvenisty. 1996. Characterization of a tumor-associated gene, a member of a novel family of genes encoding membrane glycoproteins. Gene 183:69-75.
6. Ben-Porath, I., C. A. Kozak, and N. Benvenisty. 1998. Chromosomal mapping of Tmp (Emp1),Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22. Genomics 49:443-447.
7. Benvenisty, N., A. Leder, A. Kuo, and P. Leder. 1992. An embryonically expressed gene is a target for c-Myc regulation via the c-Myc-binding sequence. Genes Dev. 6:2513-2523.
8. Benvenisty, N., D. M. Ornitz, G. L. Bennett, B. G. Sahagan, A. Kuo, R. D. Cardiff, and P. Leder. 1992. Brain tumours and lymphomas in transgenic mice that carry HTLV-I LTR/c-myc and Ig/tax genes. Oncogene 7:2399-2405.
9. Ben-Yosef, T., O. Yanuka, and N. Benvenisty. 1996. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast. Oncogene 13:1859-1856.
10. Blackwell, T., J. Huang, A. Ma, L. Kretzner, F. Alt, R Eisenman, and H. Welntraub. 1993. Binding of Myc proteins to canonical and noncanonical DNA sequences. Mol. Cell. Biol. 13:5216-5224.
11. Blackwell, T. K., L. Kretzner, E. M. Blackwood, R. N. Eisenman, and H. Weintraub. 1990. Sequence-specific DNA binding by the c-Myc protein. Science 250:1149-1151.
12. Blackwood, E. M., and R. N. Eisenman. 1991. Max: a helix-loop-helix zipper protein that forms a sequence-specific DMA-binding complex with Myc. Science 251:1211-1217.
13. Bolin, L., T. McNeil, L. Lucian, B. DeVaux, K. Franz-Bacon, D. Gorman, S. Zurawski, R. Murray, and T. McClanahan, 1997. HNMP-1: a novel hematopoietic and neural membrane protein differentially regulated in neural development and injury. J. Neurosci. 17:5493-5502.
14. Cardiff, R., A. Leder, A. Kuo, P. Pattengale, and P. Leder. 1993. Multiple tumor types appear in a transgenic mouse with the ras oncogene. Am. J. Pathol. 142:1199-1207.
15. Cavalieri, F., and M. Goldfarb. 1987. Growth factor-deprived BALB/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression. Mol. Cell. Biol. 7:3554-3560.
16. Chance, P. F., and K. H. Fischbeck. 1994. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum. Mol. Genet. 3:1503-1507.
17. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
18. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
19. Corden, J., B. Wasylyk, A. Buchwalder, C. P. Sassone, C. Kedinger, and P. Chambon. 1980. Promoter sequences of eukaryotic protein-coding genes. Science 209:1406-1414.
20. Cox, A., and C. Der. 1994. Biological assays for cellular transformation. Methods Enzymol. 238:277-294.
21. Dang, C. 1999. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol. Cell. Biol. 19:1-11.
22. Davis, L., and T. Halazonetis. 1993. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max. Oncogene 8:125-132.
23. Eden, A., G. Simchen, and N. Benvenisty. 1996. Two yeast homologs of ECA39, a target for c-Myc regulation, code for cytosolic and mitochondrial branched-chain amino acid aminotransferases. J. Biol. Chem. 271:20242-20245.
24. Eilers, M., D. Picard, K. R. Yamamoto, and J. M. Bishop. 1989. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature 340:66-68.
25. Elson, A., C. Deng, J. Campos-Torres, L. Donehower, and P. Leder. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Oncogene 11:181-190.
26. Elson, A., and P. Leder. 1995. Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Haras or neu. J. Biol. Chem. 270:26116-26122.
27. Evan, G., E. Harrington, A. Fanidi, H. Land, B. Amati, and M. Bennett. 1994. Integrated control of cell proliferation and cell death by the c-myc oncogene. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 345:269-275.
28. Evan, G. I., A. H. Wyllie, C. S. Gilbert, T. D. Littlewood, H. Land, M. Brooks, C. M. Waters, L. Z. Penn, and D. C. Hancock. 1992. Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128.
29. Fabbretti, E., P. Edomi, C. Brancolini, and C. Schneider. 1995. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A. Genes Dev. 9:1846-1856.
30. Facchini, L. M., and L. Z., Penn. 1998. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 12: 633-651.
31. Galaktionov, K., X. Chen, and D. Beach. 1996. Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517.
32. Galaktionov, K., A. K. Lee, J. Eckstein, G. Draetta, J. Meckler, M. Loda, and D. Beach. 1995. CDC25 phosphatases as potential human oncogenes. Science 269:1575-1577.
33. Gorman, C. M., L. F. Moffat, and B. H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
34. Grandori, C., and R. Eisenman. 1997. Myc target genes. Trends Biochem. Sci. 22:177-181.
35. Grandori, C., J. Mac, F. Siebelt, D. Ayer, and R. Eisenman. 1996. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo. EMBO J. 15:4344-4357.
36. Iyer, V., and K. Struhl. 1995. Poly(dA:dT), a ubiquitous promoter element that stimulates transcription via its intrinsic DNA structure. EMBO J. 14: 2570-2579.
37. Keath, E. J., P. G. Caimi, and M. D. Cole. 1984. Fibroblast lines expressing activated c-myc oncogenes are tumorigenic in nude mice and syngeneic animals. Cell 39:339-348.
38. Kelekar, A., and M. Cole. 1986. Tumorigenicity of fibroblast lines expressing the adenovirus E1a, cellular p53, or normal c-myc genes. Mol. Cell. Biol. 6:7-14.
39. Krane, I., and P. Leder. 1996. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12:1781-1788.
40. Lazaris-Karatzas, A., K. Montine, and N. Sonenberg. 1990. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345:544-547.
41. Lee, W., A. Haslinger, M. Karin, and R. Tjian. 1987. Activation of transcription by two factors that bind promoter and enhancer sequences of the human metallothionein gene and SV40. Nature 325:358-372.
42. Littlewood, T., D. Hancock, P. Danielian, M. Parker, and G. Evan. 1995. A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res. 23:1686-1690.
43. Lobsiger, C., J. Magyar, V. Taylor, P. Wulf, A. Welcher, Amgen EST Program, and U. Suter. 1996. Identification and characterization of a cDNA and the structural gene encoding the mouse epithelial membrane protein-1. Genomics 36:379-387.
44. Manfioletti, G., M. E. Ruaro, G. Del Sal, L. Philipson, and C. Schneider. 1990. A growth arrest-specific (gas) gene codes for a membrane protein. Mol. Cell. Biol. 10:2924-2930.
45. Marcu, K. B., S. A. Bossone, and A. J. Patel. 1992. myc function and regulation. Annu. Rev. Biochem. 61:809-860.
46. Marhin, W., S. Chen, L. Facchini, J. Fornace, and L. Penn. 1997. Myc represses the growth arrest gene gadd45. Oncogene 14:2825-2834.
47. Marvin, K. W., W. Fujimoto, and A. M. Jetten. 1995. Identification and characterization of a novel squamous cell-associated gene related to PMP22. J. Biol. Chem. 270:28910-28916.
48. Meichle, A., A. Philipp, and M. Eilers. 1992. The functions of Myc proteins. Biochim. Biophys. Acta 1114:129-146.
49. 1/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol. Cell. Biol. 15:2527-2535.
50. Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
51. Patel, P. I., and J. R. Lupski. 1994. Charcot-Marie-Tooth disease: a new paradigm for the mechanism of inherited disease. Trends Genet. 10:128-133.
52. Pena, A., C. D. Reddy, S. Wu, N. J. Hickok, E. P. Reddy, G. Yumet, D. R. Soprano, and K. J. Soprano. 1993. Regulation of human ornithine decarboxylase expression by the c-Myc.Max protein complex. J. Biol. Chem. 268: 27277-27285.
53. Potter, H., L. Weir, and P. Leder. 1984. Enhancer-dependent expression of human kappa immunoglobulin genes introduced into pre-B lymphocytes by electroporation. Proc. Natl. Acad. Sci. USA 81:716 1-7165.
54. Prendergast, G. C., and E. B. Ziff. 1992. A new bind for Myc. Trends Genet. 8:91-96.
55. Ray, R., S. Thomas, and D. Miller. 1989. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice. Oncogene 4:593-600.
56. Reisman, D., N. B. Elkind, B. Roy, J. Beamon, and V. Rotter. 1993. c-Myc transactivates the p53 promoter through a required downstream CACGTG motif. Cell Growth Differ. 4:57-65.
57. Ruegg, C. L., H. Y. Wu, F. F. Fagnoni, E. G. Engleman, and R. Laus. 1996. B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain. J. Immunol. 157:72-80.
58. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
59. Schiemann, S., M. Ruckels, L. H. Engelholm, M. Schwirzke, N. Brunner, and U. H. Weidle. 1997. Differential gene expression in human mammary carcinoma cells: identification of a new member of a receptor family. Anticancer Res. 17:13-20.
60. Shim, H., C. Dolde, B. C. Lewis, C. S. Wu, G. Dang, R. A. Jungmann, R. Dalla-Favera, and C. V. Dang. 1997. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc. Natl. Acad. Sci. USA 94:6658-6663.
61. Small, M. B., N. Hay, M. Schwab, and J. M. Bishop. 1987. Neoplastic transformation by the human gene N-myc. Mol. Cell. Biol. 7:1638-1645.
62. Snipes, G. J., U. Suter, and E. M. Shooter. 1993. Human peripheral myelin protein-22 carries the L2/HNK-1 carbohydrate adhesion epitope. J. Neurochem. 61:1961-1964.
63. Stewart, T. A., P. K. Pattengale, and P. Leder. 1984. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 38:627-637.
64. Stone, J., T. de Lange, G. Ramsay, E. Jakobovits, J. M. Bishop, H. Varmus, and W. Lee. 1987. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol. 7:1697-1709.
65. Suter, U., and G. J. Snipes. 1995. Peripheral myelin protein 22: facts and hypotheses. J. Neurosci. Res. 40:145-151.
66. Suter, U., G. J. Snipes, S. R. Schoener, A. A. Welcher, S. Pareek, J. R. Lupski, R. A. Murphy, E. M. Shooter, and P. I. Patel. 1994. Regulation of tissue-specific expression of alternative peripheral myelin protein-22 (PMP22) gene transcripts by two promoters. J. Biol. Chem. 269:25795-25808.
67. 1 serum response genes and identification of a subset regulated by conditional myc expression. Mol. Biol. Cell 5:375-388.
68. Taylor, V., and U. Suter. 1996. Epithelial membrane protein-2 and epithelial membrane protein-3: two novel members of the peripheral myelin protein 22 gene family. Gene 175:115-120.
69. Taylor, V., A. A. Welcher, Amgen EST Program, and U. Suter. 1995. Epithelial membrane protein-1, peripheral myelin protein 22, and lens membrane protein 20 define a novel gene family. J. Biol. Chem. 270:28824-28833.
70. Wagner, A. J., C. Meyers, L. A. Laimins, and N. Hay. 1993. c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ. 4:879-883.
71. Wulf, G., C. Adra, and B. Lim. 1993. Inhibition of hematopoietic development from embryonic stem cells by antisense vav RNA. EMBO J. 12:5065-5074.
72. + exchanger gene expression. Role of a novel poly(dA · dT) element in regulation of the NHE1 promoter. J. Biol. Chem. 271:20444-20449.
73. Zoidl, G., K. S. Blass, D. D'Urso, C. Schmalenbach, and H. W. Muller. 1995. Retroviral-mediated gene transfer of the peripheral myelin protein PMP22 in Schwann cells: modulation of cell growth. EMBO J. 14:1122-1128.
74. Zoidl, G., D. D'Urso, K. S. Blass, C. Schmalenbach, R. Kuhn, and H. W. Muller. 1997. Influence of elevated expression of rat wild-type PMP22 and its mutant PMP22Trembler on cell growth of NIH3T3 fibroblasts. Cell Tissue Res. 287:459-470.